Effect of potassium channel blockade and alpha 2-adrenoceptor activation on the release of nitric oxide from non-adrenergic non-cholinergic nerves

Br J Pharmacol. 1994 May;112(1):341-5. doi: 10.1111/j.1476-5381.1994.tb13074.x.

Abstract

1. Using a superfusion bioassay cascade, we studied the effect of K+ channel blockers and alpha 2-adrenoceptor agents on the release of a transferable factor, previously characterized as nitric oxide (NO) or a nitric oxide-related substance (NO-R), in response to non-adrenergic non-cholinergic (NANC) nerve stimulation in the canine ileocolonic junction (ICJ). 2. The non-selective K+ channel blockers, 4-aminopyridine (4-AP, 50 microM) and tetraethylammonium (TEA, 1 mM) and the more selective blocker of Ca(2+)-activated K+ channels, charybdotoxin (Leiurus quinquestriatus venom (LQV), 0.4 microgram ml-1), significantly enhanced the release of NO-R induced by low frequency stimulation (2-4 Hz). In the presence of 4-AP and TEA, the release of NO-R was nearly abolished by tetrodotoxin (2 microM), and by L-NG-nitroarginine (L-NOARG, 0.1 mM). Relaxations induced by direct injection of exogenous NO (5-50 pmol) or nitroglycerin (GTN, 10-30 pmol) onto the rabbit aortic detector ring were not affected. 3. The alpha 2-adrenoceptor agonist, UK-14,304 (0.3 microM) inhibited the release of NO-R induced by low (2-4 Hz), but not that induced by high (16 Hz), frequency stimulation. This inhibitory effect was completely reversed by the alpha 2-adrenoceptor antagonist, yohimbine (0.3 microM). Neither UK-14,304 nor yohimbine affected the relaxations induced by exogenous NO (5 pmol) or GTN (10 pmol) on the aortic detector ring.3+

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Aminopyridine / pharmacology
  • Adrenergic alpha-Agonists / pharmacology*
  • Animals
  • Arginine / analogs & derivatives
  • Arginine / pharmacology
  • Autonomic Nervous System / drug effects
  • Autonomic Nervous System / metabolism*
  • Autonomic Nervous System / physiology
  • Brimonidine Tartrate
  • Charybdotoxin
  • Dogs
  • Electric Stimulation
  • Female
  • Male
  • Nitric Oxide / antagonists & inhibitors
  • Nitric Oxide / metabolism*
  • Nitroarginine
  • Potassium Channels / drug effects*
  • Potassium Channels / metabolism
  • Quinoxalines / pharmacology
  • Receptors, Adrenergic, alpha-2 / drug effects*
  • Scorpion Venoms / pharmacology
  • Tetraethylammonium Compounds / pharmacology
  • Tetrodotoxin / pharmacology
  • Yohimbine / pharmacology

Substances

  • Adrenergic alpha-Agonists
  • Potassium Channels
  • Quinoxalines
  • Receptors, Adrenergic, alpha-2
  • Scorpion Venoms
  • Tetraethylammonium Compounds
  • Charybdotoxin
  • Nitroarginine
  • Yohimbine
  • Nitric Oxide
  • Tetrodotoxin
  • Brimonidine Tartrate
  • Arginine
  • 4-Aminopyridine